These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35863593)

  • 1. Enhancement of transdermal permeation of cannabinoids and their pharmacodynamic evaluation in rats.
    Salau O; Bagde A; Kalvala A; Singh M
    Int J Pharm; 2022 Aug; 624():122016. PubMed ID: 35863593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.
    Deiana S; Watanabe A; Yamasaki Y; Amada N; Arthur M; Fleming S; Woodcock H; Dorward P; Pigliacampo B; Close S; Platt B; Riedel G
    Psychopharmacology (Berl); 2012 Feb; 219(3):859-73. PubMed ID: 21796370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure.
    Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
    De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
    Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews.
    Rock EM; Goodwin JM; Limebeer CL; Breuer A; Pertwee RG; Mechoulam R; Parker LA
    Psychopharmacology (Berl); 2011 Jun; 215(3):505-12. PubMed ID: 21243485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways.
    Viereckl MJ; Krutsinger K; Apawu A; Gu J; Cardona B; Barratt D; Han Y
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Enhanced Therapeutic Efficacy of Dapoxetine HCl by Nano-Vesicle Transdermal Gel for Treatment of Carrageenan-Induced Rat Paw Edema.
    Salem HF; Nafady MM; Kharshoum RM; Abd El-Ghafar OA; Farouk HO
    AAPS PharmSciTech; 2020 Apr; 21(3):113. PubMed ID: 32291553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Non-psychotropic Plant-derived Cannabinoids on Bladder Contractility: Focus on Cannabigerol.
    Pagano E; Montanaro V; Di Girolamo A; Pistone A; Altieri V; Zjawiony JK; Izzo AA; Capasso R
    Nat Prod Commun; 2015 Jun; 10(6):1009-12. PubMed ID: 26197538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Rapid LC-MS/MS Method for the Quantification of Cannabidiol, Cannabidivarin, Δ
    Piscitelli F; Pagano E; Lauritano A; Izzo AA; Di Marzo V
    Anal Chem; 2017 Apr; 89(8):4749-4755. PubMed ID: 28343385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties.
    Perez E; Fernandez JR; Fitzgerald C; Rouzard K; Tamura M; Savile C
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety assessment and redox status in rats after chronic exposure to cannabidiol and cannabigerol.
    Polanska HH; Petrlakova K; Papouskova B; Hendrych M; Samadian A; Storch J; Babula P; Masarik M; Vacek J
    Toxicology; 2023 Apr; 488():153460. PubMed ID: 36796712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery of diclofenac sodium through rat skin from various formulations.
    Sarigüllü Ozgüney I; Yeşim Karasulu H; Kantarci G; Sözer S; Güneri T; Ertan G
    AAPS PharmSciTech; 2006 Oct; 7(4):88. PubMed ID: 17233540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.
    Swortwood MJ; Newmeyer MN; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2017 Jun; 9(6):905-915. PubMed ID: 27647820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers.
    Paudel KS; Hammell DC; Agu RU; Valiveti S; Stinchcomb AL
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1088-97. PubMed ID: 20545522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of Δ8-THC, Δ9-THC, Cannabidiol and 10 Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS-MS.
    Lin L; Amaratunga P; Reed J; Huang P; Lemberg BL; Lemberg D
    J Anal Toxicol; 2022 Feb; 46(1):76-88. PubMed ID: 33270860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.
    Hill AJ; Jones NA; Smith I; Hill CL; Williams CM; Stephens GJ; Whalley BJ
    Neurosci Lett; 2014 Apr; 566():269-74. PubMed ID: 24642454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
    Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
    J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Cannabidiol and Tetrahydrocannabivarin on Paclitaxel-induced neuropathic pain in rodents.
    Kumar Kalvala A; Bagde A; Arthur P; Kumar Surapaneni S; Ramesh N; Nathani A; Singh M
    Int Immunopharmacol; 2022 Jun; 107():108693. PubMed ID: 35303507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
    McPartland JM; Duncan M; Di Marzo V; Pertwee RG
    Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.